ClinicalTrials.gg
RecruitingNCT06532903Updated Aug 1, 2024

Functional Recovery From Facial Paralysis

An interventional study of Selective muscle electrostimulation with exponential current and Facial muscle reeducation in front of the mirror in Peripheral Facial Paralysis, Facial Palsy and Synkineses, sponsored by Universidad Nacional del Nordeste, Argentina. Recruiting at 1 site in Argentina. Per ClinicalTrials.gov, last updated 2024-08-01.

Sponsored by Universidad Nacional del Nordeste, Argentina · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Registered 1 year after the study started (first participant enrolled Jun 2023, registered Jun 2024).
  • Started Jun 2023; still recruiting 3 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Sex
All
01

Study summary

This is a controlled, single-blind (hybrid) clinical investigation that aims to analyze the process of recovery of muscle function in people with peripheral facial paralysis who receive kinesthetic treatment with electrostimulation compared to those who receive treatment without electrostimulation, in the UNNE University Kinesiology Service, during the period 2023-2025, to promote early reintegration into their social activities of daily life.

An initial evaluation will be carried out, the movements that cause the requested gestures will be observed and recorded and recorded on a monitoring sheet and on video. The House Brackman and Sunnybrook scale will be used to measure functional outcomes. The initial and final evaluations will be external and blind. Patients will sign informed consent approved by Resolution No 04/23 of the Health Sciences Research Bioethics Committee.

The following inclusion criteria will be taken into account: patients with a medical referral that indicates a diagnosis of peripheral facial paralysis, Bell's palsy, frigori facial paralysis, idiopathic facial paralysis, who have not received previous kinesic treatment. Patients with central facial paralysis (associated with stroke), with peripheral facial paralysis of more than 6 months of evolution, who present dermal lesions that interfere with the application of electrical currents (open wounds, lacerations or burns) will be excluded from the study. ) In addition, those patients who attend with a medical prescription that advises in writing against the use of electrostimulation will be excluded.

Read the detailed description

Methodology:

Study type: experimental Design: Controlled clinical research, single blind (hybrid). Universe: all people with peripheral facial paralysis or Bell's palsy in the City of Corrientes.

Units of analysis: each person with peripheral facial paralysis or Bell's palsy who attends the UNNE University Kinesiology Service. This center is taken as a reference, since it is a reference place for the referral of patients with this diagnosis, it is open to the general public and free of charge.

Sampling: a probabilistic sampling will be carried out. Sample size (n): 152 patients Expected loss ratio (R): 15% Loss-adjusted sample: 179 patients

The following inclusion criteria will be taken into account:

-Patients with a medical referral that indicates as a diagnosis: peripheral facial paralysis, Bell's palsy, frigori facial paralysis, idiopathic facial paralysis, who have NOT received prior kinesic treatment.

Patients with central facial paralysis (facial paralysis associated with stroke), with peripheral facial paralysis of more than 6 months' duration, will be excluded from the study. Patients who present dermal lesions that interfere with the application of electrical currents (open wounds, lacerations or burns) and/or who attend with a medical prescription that advises against the use of electrostimulation in writing.

Two groups will be defined:

  • Control: Patients with peripheral facial paralysis who will receive standard kinesic treatment (facial muscle reeducation without selective muscle electrostimulation)
  • Study: Patients with peripheral facial paralysis who will receive standard kinesic treatment (with muscle reeducation) and selective muscle electrostimulation.

The assignment of patients to each group will be carried out in a systematic random manner.

People who voluntarily attend the University Kinesiology Service in the indicated period will be selected based on the aforementioned inclusion and exclusion criteria. Patients will be assigned to each group in a systematic random manner. A characteristic of controlled clinical trials is double blinding, a condition that will be resigned since it is impossible for the kinesiologist to ignore what treatment is assigned to the patient, since he himself is the one who applies it. On the other hand, it is worth mentioning that the blinding that will be included will be the initial and final evaluation of the people included in the study, that is; A group of professionals trained in facial evaluation scales will receive the initial and final videos of the patients without knowing the treatment they received.

study variables:

Functional recovery from facial paralysis dimension:

-Specific muscle function: - Ability to close eyes completely and symmetrically.

Mouth occlusion at the beginning and end of treatment -Value: Does not occlude: 0 - Occludes: 1 Capacity to contain liquids and air. VALUE: Does not contain: 0 Contains: 1

-Functional recovery time. Number of treatment sessions carried out until the person's kinesic discharge.

VALUE: Short term: up to 7 sessions -Medium term: up to 15 sessions -Long term:

greater than 15 sessions

  • Facial symmetry: The correspondence between the size, shape and location of facial features on one side with respect to the opposite side. Present: 1 Absent: 0
  • Laterality of paralysis Side of peripheral facial paralysis Right: 1 Left:2

Individual characteristics of people with peripheral facial paralysis

  • Age
  • sexual identity

Days of evolution of the PFP: Number of days of evolution of the paralysis before starting treatment -Short term: less than 7 days -Medium term: up to 15 days -Long term: greater than 15 days

previous pathological history

presence of synkinesis

Facial function assessment scales: House Brackman and Sunnybrook

Registration method

To record the data obtained, the following is done: filming, photographic recording of facial muscle functions with a NIKON DSC COOLPIX B500® camera; For the written record, a daily monitoring sheet is used that includes: anamnesis, clinical evaluation, functional evaluation, electrostimulation parameters and re-education.

Position of the patient for taking photographic and videographic records: the patients are seated in front of the camera, placed on a tripod, focusing on the face in the foreground, taking an imaginary biclavicular lower line as the frame limit, with a clear background. . In this way, the initial evaluation, evolution and final assessment of each patient was documented.

Filming and photographic records were carried out without zoom to avoid distortions in the image or defects in its resolution.

DESCRIPTION OF THE TREATMENT APPLIED TO EACH GROUP FACIAL REEDUCATION Protocol Muscle re-education: Symmetrical facial movements are requested, activating the muscles of the affected side, avoiding the participation of the unaffected side. We work with the patient sitting in front of a mirror, asking him to perform the following actions or gestures: raise his eyebrows, frown, close his eyes (tightly and blink), smell an unpleasant odor, show his fangs, blow a kiss, blow , fake smile (lip corner pulled back horizontally), frank smile (lip corner pulled back and up, showing teeth), kiss and "pout". The functional capacity of the mouth was trained, inflating the cheekbones and moving air from one side to the other, avoiding compensations.

Depending on the degree of facial dysfunction and its condition, the kinesiologist performs irradiation, stretch reflex, movement facilitation and/or its inhibition. Three series of five repetitions of each gesture described were done.

Selective muscle electrostimulation protocol for the study group:

Each patient underwent an "electroevaluation" with an exponential current generating device (NEUROMATIC 700 brand Meditea®) which consisted of a test using facial stimulation with different pulse widths (in milliseconds) and intensities (in milliamps) with current. exponential. It was observed in which parameters a frank, visible and selective contraction was achieved, avoiding muscle fatigue. This procedure was performed daily, allowing selective muscle stimulation and a dosed application of the physical agent used.

Technique for applying selective muscle electrostimulation: a direct technique was used with a dispersive electrode in the patient's cervical spine and an active punctal electrode in the facial muscles.

Ethical considerations:

The process of reading, understanding, accepting and signing the informed consent was carried out in a prior interview, before starting the treatment. This document included the treatment methods used, the objectives of the study, the free follow-up, the commitment of both parties, as well as the formal dissemination mechanisms used regarding the results of the work to each participating patient. The risks inherent to kinesic practice were detailed and the patient was informed of the mechanisms used to ensure the quality of care provided.

02

Conditions studied

  • Peripheral Facial Paralysis
  • Facial Palsy
  • Synkineses

Browse trials for

Keywords

  • electrostimulation
  • peripheral facial paralysis
  • facial muscles
  • mime
  • selective muscle electrostimulation
03

In context

Facial Paralysis

81 studies on the registry are indexed under Facial Paralysis; 28 are open to participants now.

This study's planned enrollment of 50 is close to the median of 50 across 59 interventional studies indexed under Facial Paralysis.

Browse Facial Paralysis studies →

Lead sponsor

This is the only study on the registry with Universidad Nacional del Nordeste, Argentina as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with a medical referral that indicates as a diagnosis:
  • Peripheral facial paralysis
  • Bell's palsy
  • Frigori facial paralysis
  • Idiopathic facial paralysis, who have NOT received prior kinesic treatment.

Exclusion criteria

Exclusion Criteria:

  • Patients with central facial paralysis (facial paralysis associated with stroke)
  • Patients with peripheral facial paralysis of more than 6 months' duration, will be excluded from the study.
  • Patients who present skin lesions that interfere with the application of electrical currents (open wounds, lacerations or burns)
  • Patients who attend with a medical prescription that advises against the use of electrostimulation in writing.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Study group

    Patients with peripheral facial paralysis who will receive muscle reeducation in front of the mirror and selective muscle electrostimulation with exponential currents

    Other: Selective muscle electrostimulation with exponential current

  • Active comparator
    control group

    Patients with peripheral facial paralysis who will receive facial muscle reeducation in front of the mirror without selective muscle electrostimulation with exponential current

    Other: Facial muscle reeducation in front of the mirror

Interventions

  • OtherSelective muscle electrostimulation with exponential current

    An electroevaluation will be performed, with an exponential current generator equipment, using Meditea® brand Neuromatic 700 equipment, which consists of a first application of the current, the pulse width (in milliseconds) in which a contraction is achieved will be sought. frank, visible and selective of the facial muscle that is being stimulated. The purpose is to identify the pulse width and the lowest intensity to obtain a frank, visible and selective contraction, understood as the best quality.

  • OtherFacial muscle reeducation in front of the mirror

    Muscle re-education: Symmetrical facial movements will be requested, activating the muscles of the affected side, avoiding the participation of the unaffected side. We will work with the patient sitting in front of a mirror, asking him to perform the following actions or gestures: raise his eyebrows, frown, close his eyes (tightly and blink), smell an unpleasant odor, show his fangs, blow a kiss, blow , fake smile (lip corner pulled back horizontally), frank smile (lip corner pulled back and up, showing teeth), kiss and "pout". The functional capacity of the mouth will be trained, inflating the cheekbones and moving the air from one side to the other, avoiding compensations. Depending on the degree of facial dysfunction and its condition, the kinesiologist will perform a stretch reflex, facilitation of movement and/or inhibition of it. Three series of five repetitions of each gesture described will be done.

06

What researchers measure

Primary outcomes

  1. FUNCTIONAL RECOVERY

    ability to make facial gestures evaluated using the House Brackman scale and the Sunnybroock system

    Time frame: 24 months

  2. Functional recovery time

    number of sessions necessary to achieve recovery of facial muscle function and ability to make facial gestures.

    Time frame: 24 months

07

Study locations

1 of 1 sites recruiting
  • Servicio Universitario de Kinesiologia
    Corrientes, 3400, Argentina
    Recruiting
    • ELIZABETH RUTH LORENA ACOSTA, INVESTIGADOR · Contactloresukunne@gmail.com · +5493794710307
    • MARIA MARCELA BARRIOS, INVESTIGADOR · Contactmarcebarrios13@med.unne.edu.ar · +54 9 3794 57-5048
    • Jessica Andrea Isabel ZALAZAR CINAT · Principal investigator
08

References and documents

Publications

  • Di Pietro A, Cameron M, Campana V, Leyes L, Zalazar Cinat JAI, Lochala C, Johnson CZ, Hilldebrand A, Loyo M. Efficacy of adding selective electrical muscle stimulation to usual physical therapy for Bell's palsy: immediate and six-month outcomes. Eur J Transl Myol. 2023 Oct 24;33(4):11630. doi: 10.4081/ejtm.2023.11630. PubMed 37877154 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2023 (actual). Primary completion is estimated for Dec 2024, 18 months after the start.

Of 37 interventional studies with no phase under Facial Paralysis, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 68. This study's planned 18 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 24, 2024
First posted
Aug 1, 2024
StartActual
Jun 1, 2023
Primary completionEst.
Dec 31, 2024
CompletionEst.
Dec 31, 2025
Last update
Aug 1, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06532903
Lead sponsor
Universidad Nacional del Nordeste, Argentina
Collaborators
National Council of Scientific and Technical Research, Argentina
Responsible party
Jessica Andrea Isabel Zalazar Cinat (Master in Research in Health Sciences - Graduate in Kinesiology and Physiatry, Universidad Nacional del Nordeste, Argentina) — Principal investigator
First posted
Aug 1, 2024
Start date
Jun 1, 2023
Primary completion
Dec 31, 2024 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Aug 1, 2024

Study contacts

JESSICA A ZALAZAR, INVESTIGADOR
Contact
jessicazalazarcinat@med.unne.edu.ar
+5493624791093
LAURA E LEYES, INVESTIGADOR
Contact
lauraleyes@med.unne.edu.ar
+5493794759014
JESSICA A ZALAZAR, INVESTIGADOR
study director · Universidad Nacional del Nordeste, Argentina

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion